Review of frovatriptan in the treatment of migraine

References

• AfridiSKGiffinNJKaubeHA positron emission tomographic study in spontaneous migraineArch Neurol20056212705 3416087768
   PubMedGoogle Scholar
• AllaisGAcutoGCabarrocasXEfficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraineNeurol Sci200627Suppl 2S193716688629
   PubMed Web of Science ®Google Scholar
• BahraAMatharuMSBuchelCBrainstem activation specific to migraine headacheLancet200135710161711293599
   PubMed Web of Science ®Google Scholar
• BrandesJLSmithTDiamondMOpen-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraineHeadache2007478869417578540
   PubMed Web of Science ®Google Scholar
• BolayHReuterUDunnAKIntrinsic brain activity triggers trigeminal meningeal afferents in a migraine modelNat Med200281364211821897
   PubMed Web of Science ®Google Scholar
• BrownAMHoMThomasDRComparison of functional effects of frovatriptan (VML 251), sumatriptan, and naratriptan on human recombinant 5-HT1 and 5-HT7 receptors [abstract]Headache199838376
   Google Scholar
• BrownAMParsonsAARavalPSB 209509 (VML 251), a potent constrictor of rabbit basilar artery with high affinity and selectivity for human 5-HT1D receptors [abstract]Br J Pharmacol1996119Suppl110P
   Google Scholar
• BuchanPThe pharmacokinetics of frovatriptan (VML 251/SB 209509), a potent selective 5-HT1B/1D agonist, following single dose administration by oral and intravenous routes to healthy male and female volunteers [abstract]Headache199838376
   Google Scholar
• BuchanPKeywoodCWardCPharmacokinetics of Frovatriptan (VML 251/SB 209509) in healthy young and elderly male and female subjects [abstract]Cephalalgia199818410
   Google Scholar
• BuchanPWadeAWardCFrovatriptan: a review of drug-drug interactionsHeadache200242Suppl 2S637312028322
   PubMed Web of Science ®Google Scholar
• BuchanPWardCZeigSFrovatriptan pharmacokinetics are unaffected during a migraine attack [abstract]Cephalalgia199919365
   Web of Science ®Google Scholar
• BursteinRCollinsBJakubowskiMDefeating migraine pain with triptans: a race against the development of cutaneous allodyniaAnn Neurol200455192614705108
   PubMed Web of Science ®Google Scholar
• CadyRElkindAGoldsteinJRandomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severeCurr Med Res Opin20042014657215383196
   PubMed Web of Science ®Google Scholar
• CohenAFvan der PostJSacksPharmacokinetics of frovatriptan in patients with renal impairment [abstract]Cephalalgia199919365
   Web of Science ®Google Scholar
• CushingDJZgombickJMNelsonDLLY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary arteryJ Pharmacol Exp Ther1996277156068667223
   PubMed Web of Science ®Google Scholar
• DoenickeABrandJPerrinVLPossible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraineLancet1988111309112897560
   PubMed Web of Science ®Google Scholar
• EbersbergerASchaibleH-GAverbeckBIs there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache?Ann Neurol20014171311198299
   PubMed Web of Science ®Google Scholar
• ElkindAHSatinLZNilaAFrovatriptan use in migraineurs with or at high risk of coronary artery diseaseHeadache2004444031015147247
   PubMed Web of Science ®Google Scholar
• FerrariMDGoadsbyPJRoonKITriptans (serotonin 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trialsCephalalgia200222633812383060
   PubMed Web of Science ®Google Scholar
• GéraudGKeywoodCSenardJMMigraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptansHeadache2003433768812656709
   PubMed Web of Science ®Google Scholar
• GeraudGSpieringsELKeywoodCTolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptanHeadache200242Suppl 2S93912028325
   PubMed Web of Science ®Google Scholar
• GoadsbyPJMigraine, aura and cortical spreading depression: why are we still talking about it?Ann Neurol2001494611198295
   PubMed Web of Science ®Google Scholar
• GoadsbyPJMigraine pathophysiologyHeadache200545Suppl 1S142415833086
   PubMed Web of Science ®Google Scholar
• GoadsbyPJEdvinssonLEkmanRRelease of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular systemAnn Neurol19882319362454066
   PubMed Web of Science ®Google Scholar
• GoadsbyPJHoskinKLThe distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical studyJ Anat1997190367759147223
   PubMed Web of Science ®Google Scholar
• GoadsbyPJHoskinKLKnightYEStimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the catPain1997a732389414053
   PubMed Web of Science ®Google Scholar
• GoadsbyPJHoskinKLKnightYEStimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the catPain1997b732389414053
   PubMed Web of Science ®Google Scholar
• GoadsbyPJOlesenJDiagnosis and management of migraineBMJ19963121279838634619
   PubMed Web of Science ®Google Scholar
• HoskinKLZagamiAGoadsbyPJStimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and catJ Anat19991945798810445825
   PubMed Web of Science ®Google Scholar
• HumphreyPPThe discovery of a new drug class for the acute treatment of migraineHeadache200747Suppl 1S10917425704
   PubMed Web of Science ®Google Scholar
• HumphreyPPFeniukWPerrenMJGR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous veinBr J Pharmacol1988941123322850055
   PubMed Web of Science ®Google Scholar
• IngvardsenBKLaursenHOlsenUBPossible mechanism of c-fos expression in trigeminal nucleus caudalis following spreading depressionPain1997a72407159313281
   PubMed Web of Science ®Google Scholar
• IngvardsenBKLaursenHOlsenUBComment on Ingvardsen et alPain1997b7240715 Reply to Moskowitz et al. Pain, 1998; 76: 266–79313281
   PubMed Web of Science ®Google Scholar
• JoutelADucrosAVahediKGenetic heterogeneity of familial hemiplegic migraineAm J Hum Genet1994551166727977376
   PubMed Web of Science ®Google Scholar
• KaubeHKeayKAHoskinKLExpression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical cord following stimulation of the superior sagittal sinus in the catBrain Res199362995102 408287282
   PubMed Web of Science ®Google Scholar
• KelmanLThe premonitory symptoms (prodrome): a tertiary care study of 893 migraineursHeadache2004448657215447695
   PubMed Web of Science ®Google Scholar
• KnightYEBartschTKaubeHP/Q-type calcium channel blockade in the PAG facilitates trigeminal nociception: a functional genetic link for migraine?J Neurosci200222RC21311880534
   PubMed Web of Science ®Google Scholar
• KnightYEGoadsbyPJThe periaqueductal gray matter modulates trigeminovascular input: a role in migraine?Neurosci2001106793800
   PubMed Web of Science ®Google Scholar
• LeonardiMSteinerTJScherATLiptonRBThe global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF)J Headache Pain200564294016388337
   PubMedGoogle Scholar
• LiptonRBDisability assessment as a basis for stratified careCephalalgia199818Suppl 2240439793711
   PubMed Web of Science ®Google Scholar
• LiptonRBBigalMEDiamondMMigraine prevalence, disease burden, and the need for preventive therapyNeurology200768343917261680
   PubMed Web of Science ®Google Scholar
• LongmoreJShawDSmithDDifferential distribution of 5-HT1D- and 5-HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugsCephalalgia1997178338429453271
   PubMed Web of Science ®Google Scholar
• LucasCStrategies to improve migraine treatment resultsDrugs200666Suppl 3916
   Google Scholar
• MacGregorEAKeywoodCFrovatriptan is effective in menstrually associated migraineCephalalgia200020345
   Google Scholar
• MalickABursteinRPeripheral and central sensitization during migraineFunct Neurol200015Suppl 3283511200798
   PubMed Web of Science ®Google Scholar
• MannixLKLoderENettRRizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studiesCephalalgia2007a274142117448179
   PubMed Web of Science ®Google Scholar
• MannixLKSavaniNLandySEfficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studiesHeadache2007b4710374917635595
   PubMed Web of Science ®Google Scholar
• MatharuMSBartschTWardNCentral neuromodulation in chronic migraine patients with suboccipital stimulators: a PET studyBrain20041272203014607792
   PubMed Web of Science ®Google Scholar
• MarkowitzSSaitoKMoskowitzMANeurogenically mediated leakage of plasma proteins occurs from blood vessels in dura mater but not brainJ Neurosci198774129363694267
   PubMed Web of Science ®Google Scholar
• MoskowitzMABasic mechanisms in vascular headacheNeurol Clin19908801152175382
   PubMed Web of Science ®Google Scholar
• MoskowitzMANeurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends Pharmacol Sci199213307111329294
   PubMed Web of Science ®Google Scholar
• MoskowitzMANeurogenic inflammation in the pathophysiology and treatment of migraineNeurology19936Suppl 3S16208389008
   PubMedGoogle Scholar
• MoskowitzMANozakiKKraigRPNeocortical spreading depression provokes the expression of C-fos protein-like immunoreactivity within the trigeminal nucleus caudalis via trigeminovascular mechanismsJ Neurosci1993131167778382735
   PubMed Web of Science ®Google Scholar
• NewmanLCLiptonRBLayCLA pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraineNeurology19985130799674831
   PubMed Web of Science ®Google Scholar
• NewmanLMannixLKLandySNaratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled studyHeadache20014132485611264684
   PubMed Web of Science ®Google Scholar
• NozakiKBoccaliniPMoskowitzMAExpression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid spaceNeuroscience199249669801501769
   PubMed Web of Science ®Google Scholar
• RapoportARyanRGoldsteinJDose range-finding studies with frovatriptan in the acute treatment of migraineHeadache200242Suppl 2S748312028323
   PubMed Web of Science ®Google Scholar
• RapoportAMTepperSJBigalMEThe triptan formulations. How to match patients and productsCNS Drugs2003174314712697002
   PubMed Web of Science ®Google Scholar
• RussellMBIseliusLOlesenJInvestigation of the inheritance of migraine by complex segregation analysisHum Genet199596726308522335
   PubMed Web of Science ®Google Scholar
• RyanRGeraudGGoldsteinJClinical efficacy of frovatriptan: placebo-controlled studiesHeadache200242Suppl 2S849212028324
   PubMed Web of Science ®Google Scholar
• SantanelloNCDaviesGAllenCDeterminants of migraine-specific quality of lifeCephalalgia200222680512383065
   PubMed Web of Science ®Google Scholar
• SilbersteinSDPractice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology2000557546210993991
   PubMed Web of Science ®Google Scholar
• SilbersteinSDElkindAHSchreiberCA randomized trial of frovatriptan for the intermittent prevention of menstrual migraineNeurology200427261915277618
   PubMed Web of Science ®Google Scholar
• SilbersteinSDLiptonRBGoadsbyPJHeadache in Clinical Practice20022London, UKMartin Dunitz
   Google Scholar
• StewartMNapierCMKatugampolaSDThe binding affinity and functional activity of eletriptan and other 5-HT1B/1D agonists at the human recombinant 5-HT1B and 5-HT1D receptors [abstract]Br J Pharmacol199912793P
   Web of Science ®Google Scholar
• TuchmanMHeeAEmeribeUEfficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraineCNS Drugs20062010192617140280
   PubMed Web of Science ®Google Scholar
• UddmanREdvinssonLEkmanRInnervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance PNeurosci Lett19856213162415882
   PubMed Web of Science ®Google Scholar
• UlrichVGervilMKyvikKOEvidence of a genetic factor in migraine with aura: a population based Danish twin studyAnn Neurol19994524269989627
   PubMed Web of Science ®Google Scholar
• WeillerCMayALimmrothVBrain stem activation in spontaneous human migraine attacksNat Med1995a1658607585147
   PubMed Web of Science ®Google Scholar
• WeillerCMayALimmrothVBrain stem activation in spontaneous human migraine attacksNat Med1995b1658607585147
   PubMed Web of Science ®Google Scholar